MVT-101 nanobubbles represent the next generation of Microvascular Therapeutics’ ultrasound-activated delivery technology. Unlike conventional microbubbles, MVT-101 nanobubbles are sub-micron lipid spheres engineered to penetrate deep into the microvasculature and respond precisely to focused ultrasound energy.
When exposed to controlled acoustic fields, these nanoscale particles can phase-shift into microbubbles, amplifying localized cavitation effects that enhance blood-flow restoration or targeted therapeutic delivery.
Key Features
Advanced phase-shift nanobubble formulation (~250 nm diameter)
Designed for ultrasound-mediated therapy and vascular intervention
Enables deep penetration into thrombi or tumor microenvironments
Converts to microbubbles under ultrasound for targeted acoustic activation
Built on MVT’s neutral lipid platform for biocompatibility and versatility
Nanobubbles
Product Name: MVT-101 (Phase-Shift Nanobubbles)
Formulation: Sterile lipid nanobubble suspension
Fill Volume: 1.5 mL per vial
Container Type: 2R borosilicate glass vial with sterile rubber stopper and aluminum seal
Appearance: Slightly opalescent, colorless liquidStorage Conditions: Store at 5 °C in a refrigerator. Do not freeze.
Handling Instructions: Inspect visually for particulate matter or discoloration prior to use.
